# Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort

> **NCT06256705** · NA · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 80 (estimated)

## Conditions studied

- Gastroenteropancreatic Neuroendocrine Tumor
- Radiotherapy

## Interventions

- **OTHER:** Simultaneous 68Ga-DOTATOC PET-MRI

## Key facts

- **NCT ID:** NCT06256705
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-25
- **Primary completion:** 2028-03-25
- **Final completion:** 2029-09-25
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06256705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06256705, "Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06256705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*